Moreover, longitudinal tracking of the immune response during the substantial reductions in pathogen load induced by the induction phase of anti-TB treatment showed an increase in dual IFN-γ/IL-2-secreting T-cells after treatment suggesting that this shift could also serve as a biomarker of treatment response [27]. Here, IL2 is linked to tuberculosis.